• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number RF310F
Device Problem Difficult to Remove (1528)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 12/02/2009
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately seven months of post deployment, venogram was performed which showed thrombus in the cava upto including the inferior vena cava filter extending slightly upto above the inferior vena cava filter but stopping before getting upto the renal veins.The next day, ekosonic endovascular system thrombolysis and thrombus aspiration from inferior vena cava filter was performed.Post ekos thrombolysis completion venogram was performed which showed the inferior vena cava was now widely patent except for some residual thrombus left in the inferior vena cava filter for a patient with caval iliofemoral thrombosis.Around five months later, inferior vena cava filter retrieval was performed.The retrieval capture device was advanced down over the filter and then with the usual maneuvers, the filter was retrieved into the sheath and pulled out of the patient.Completion venogram showed normal looking inferior vena cava.The patient tolerated the procedure without problems.Therefore, the investigation is inconclusive for retrieval difficulties.Additionally, it can be confirmed that the patient experienced thrombus above the level of filter post deployment.However, the relationship to the filter is unknown.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 03/2012).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.The device was removed percutaneously after an attempted but unsuccessful percutaneous removal procedure.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 FILTER SYSTEM - FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key12201335
MDR Text Key262629893
Report Number2020394-2021-80663
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062887
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 07/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF310F
Device Lot NumberGFTB0035
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/24/2021
Initial Date FDA Received07/21/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ROCEPHIN, COUMADIN AND HEPARIN
Patient Outcome(s) Other;
Patient Age49 YR
-
-